- 47 min ago Did You Know These Side Effects Of Green Tea?
- 1 hr ago 9 Skin Care Tips You Need To Follow This Winter Season
- 2 hrs ago Kangana Ranaut Inspires Us To Update Our Wardrobe With A Ralph Lauren Suit
- 2 hrs ago Umang 2020: Raveena Tandon And Manisha Koirala Show Us How To Look Stylish Yet Distinctive
- News Controversy over birthplace of Saibaba resolved after Uddhav Thackeray hold meeting
- Movies SP Balasubrahmanyam To Sing A Special Track For Puneeth Rajkumar’s Maya Bazaar
- Technology Jio Working On UPI Payments Via MyJio App To Compete With Google Pay
- Sports Australian Open 2020: Barty survives Tsurenko scare, Venus marvels at Coco
- Automobiles Maruti Suzuki Celerio BS6 Models Launched In India Starting At Rs 4.41 Lakh
- Travel 7 Patriotic Places To Visit This Republic Day
- Finance New Gold Hallmarking Rules: 5 Things To Know
- Education IIM Bangalore Women In Leadership Course Tanmatra
Alzheimer's disease is an irreversible, progressive brain disorder that causes the brain cells to degenerate and die, resulting in a decline in thinking, memory, behavioural and social skills.
According to the Alzheimer's Association, more than 4 million people in India have some form of dementia. It is estimated that at least 44 million people are living with dementia.
New treatments are still under way to stop, slow or prevent Alzheimer's disease and some of them have been unsuccessful.
The brain disorder is caused by the accumulation of plaque deposits in the brain, which eventually becomes toxic to brain cells. These plaque deposits are one of the biggest problems that are coming in the way to finding a cure for Alzheimer's disease because it's impossible to clear out the deposits from the brain tissue.
However, in a very recent breakthrough for Alzheimer's disease, United Neuroscience, a biotech company founded by Dr Chang Yi Wang, a prolific bio-inventor, her daughter Mei Mei Hu, and son-in-law, Louis Reese announced the results of Phase II a clinical trial on UB-311, an Alzheimer's vaccine.
This vaccine contains synthetic versions of amino acid chains that stimulate the antibodies to attack Alzheimer's protein in the blood, without causing any side effects. The antibodies were analysed in some patients and there was an almost 100% response rate.
Researchers believe that the vaccine can delay the onset of Alzheimer's disease by five years.
Currently, the company is working on the next clinical trial of the vaccine and its goal is to create innumerable vaccines that will be used to protect people from chronic illnesses.